Muvito (Tetracycline Hydrochloride)

Tetracycline hydrochloride, the active ingredient in Muvito, is a tetracycline‑class antibiotic presented as a topical formulation for cutaneous application. It is used to treat acne vulgaris and a range of bacterial skin infections in patients for whom a prescription‑only therapy is appropriate.

GNH USA supplies Muvito as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, ensuring quality‑assured product delivery across regulated markets, and meeting local regulatory requirements through robust logistics and traceability systems.

Muvito (tetracycline hydrochloride) is a topical antibacterial used to manage skin conditions caused by susceptible bacteria.

Acne vulgaris: reduces inflammatory lesions and bacterial colonisation on the face and trunk. Impetigo: eradicates Staphylococcus aureus and Streptococcus pyogenes causing superficial infection. Folliculitis: decreases bacterial load and associated inflammation of hair follicles. Papulopustular rosacea: helps control secondary bacterial overgrowth contributing to lesions.

Muvito may cause local and systemic adverse reactions when applied to the skin.

Common Side Effects: - Skin irritation or burning sensation at the application site. - Pruritus (itching) and mild erythema. - Dryness or peeling of the treated skin. - Increased photosensitivity to sunlight. - Transient discoloration of the skin. - Mild contact dermatitis.

Serious or Rare Side Effects: - Severe allergic reactions such as anaphylaxis. - Stevens‑Johnson syndrome or toxic epidermal necrolysis. - Extensive bullous dermatitis. - Systemic toxicity if absorbed in large amounts. - Persistent severe photosensitivity leading to blistering. - Rare cases of hepatic or renal impairment.

Before using Muvito, consider the following safety measures.

Pregnancy: consult a healthcare professional; safety data are insufficient. Breastfeeding: avoid use unless the prescriber determines benefits outweigh risks. Known hypersensitivity: discontinue immediately if allergic reactions occur. Sun exposure: limit UV exposure and use sunscreen while on therapy. Concurrent topical antibiotics: monitor for increased irritation or resistance. Store at ambient temperature: keep in the original packaging, protect from moisture and direct sunlight.

Muvito may interact with other medications; awareness of potential interactions is important.

Major Interactions (Avoid): - Systemic tetracyclines: concurrent use can lead to additive toxicity. - Topical retinoids: increased risk of severe skin irritation. - Other photosensitising agents: heightened photosensitivity.

Moderate Interactions (Monitor Closely): - Oral contraceptives: possible reduction in efficacy, advise additional contraception. - Anticoagulants (e.g., warfarin): monitor INR values for changes. - Vitamin D analogues: may increase local irritation; observe skin response.